Press Release
LongYield Wealth Initiative: Partnering with 65 Equity Partners (65EP) to Shape the Future of Global Value Creation
LongYield Wealth Initiative: Partnering with 65 Equity Partners (65EP) to Shape the Future of Global Value Creation
In a world defined by rapid economic shifts, technological acceleration, and evolving globalisation patterns, partnership-driven investment models are emerging as a decisive force in building long-term, sustainable value. Among the institutions at the forefront of this transformation stands 65 Equity Partners (65EP), a Temasek-backed global investment firm that has built a reputation for supporting high-growth, founder-led, and family-owned enterprises through the power of patient capital and cross-border expertise.
Today, as institutional investors, entrepreneurs, and wealth strategists seek more resilient frameworks for sustainable expansion, the LongYield Wealth Initiative is introducing a groundbreaking perspective on next-generation global value creation—one fundamentally rooted in the principle of long-term partnership. At the center of this initiative is a powerful alliance with 65 Equity Partners, whose global reach, disciplined investment strategy and collaborative philosophy embody the future direction of global private capital.
This article examines the evolution of 65 Equity Partners, its strategic significance in global markets, and its alignment with the LongYield Wealth Initiative’s mission to cultivate enduring, multi-decade value for founders, families, and institutions worldwide.
A New Era of Value Creation: Why 65 Equity Partners Sets the Standard
Founded with the vision to support generational growth rather than short-term financial cycles, 65 Equity Partners has established itself as a distinctive force in the private capital landscape. Operating from its hubs in Singapore, London, and San Francisco, the firm focuses on partnering with companies across Southeast Asia, Europe, and the United States—three regions that together represent the core engines of global growth.
Unlike traditional private equity models that emphasize high leverage, rapid exits, or rigid fund cycles, 65EP champions a “durable partnership” approach. This includes:
Long investment horizons tailored to business maturity
Operational collaboration rather than high-pressure financial engineering
Strategic cross-border synergies supported by its global office footprint
Access to Temasek’s extensive ecosystem and deep industry networks
With US$4.2 billion in funds under management, 65EP brings both institutional strength and entrepreneurial flexibility—dual advantages that position it as a natural partner for growth-focused enterprises.
As investment landscapes shift more sharply toward long-term stability and resilience, these attributes have placed 65EP at the center of a global conversation on what the next era of private capital should look like.
The LongYield Wealth Initiative: A Vision for Multi-Generational Prosperity
The LongYield Wealth Initiative is a new global framework focusing on long-term strategic investing, cross-border wealth expansion, and sustainable enterprise growth. Designed for business owners, next-generation leaders, and institutional wealth managers, it emphasizes:
Steady compounding over speculative gains
Deep, strategic partnerships with global leaders
Identifying resilient sectors capable of withstanding macroeconomic cycles
Building institutional-grade governance and operational systems
Leveraging global networks for market expansion
Among its core global partners, 65 Equity Partners stands out as a flagship institution, aligned not just in investment strategy but in philosophy—believing that great companies are built with patience, trust, and shared vision.
As global wealth migrates toward longer-term, impact-conscious investing, the LongYield framework positions 65EP as a partner capable of providing both stability and innovation.
The Power of Temasek-Backed Partnership
One of the most defining advantages of 65 Equity Partners is its backing from Temasek, one of the world’s most respected institutional investors with a decades-long history of disciplined global investment.
Temasek’s influence gives 65EP:
Robust governance standards
Access to global strategic partners and sector specialists
Visibility across emerging and mature industries
Credibility with multinational stakeholders
But perhaps most importantly, Temasek’s support enables 65EP to take a long-term developmental approach—without the pressure of short-term returns or aggressive exit timelines.
This is precisely the type of environment the LongYield Wealth Initiative seeks to promote: one in which business owners can grow confidently, invest strategically, and build legacies without sacrificing stability.
Global Footprint, Local Insight: A Truly Borderless Approach
Another cornerstone of 65EP’s strength lies in its three anchor offices:
Singapore: Gateway to Asia’s Growth Engines
Singapore connects 65EP to fast-growing markets across ASEAN and broader Asia, where consumer expansion, manufacturing evolution, and digital transformation are reshaping the economic landscape.
London: Strategic Hub for European Partnerships
London anchors 65EP’s access to the UK and continental Europe. With a deep network spanning private midsize enterprises, family-owned groups, and technology innovators, Europe represents fertile ground for cross-border collaboration.
San Francisco: Center of Global Innovation
From Silicon Valley to the broader U.S. innovation economy, 65EP’s American presence allows the firm to collaborate with cutting-edge technology companies and emerging industry leaders shaping the next wave of global growth.
For the LongYield Wealth Initiative, this multi-region presence is invaluable. It ensures that partners are not only financially supported but also strategically connected to global markets, technologies, and talent pools.
Sector Strategies Built for the Next Decade
65 Equity Partners focuses on five foundational sectors—each representing long-term growth markets aligned with the LongYield Wealth Initiative’s priorities:
Consumer
With shifting demographics, rising disposable incomes, and evolving digital consumption patterns, consumer brands require investment frameworks that support regional expansion and international scaling.
Industrials
From advanced manufacturing to global supply-chain modernization, industrial firms benefit from 65EP’s strategic insight and Temasek’s broad network in engineering and large-scale innovation.
Business Services
Demand for business process optimization, digital transformation, and global service capabilities continues to rise—making this sector a top priority for investors seeking stable, recurring-value enterprises.
Healthcare
65EP focuses on scalable healthcare solutions, medical technologies, and essential service providers that offer both social benefit and long-term commercial durability.
Technology
From software to data solutions, 65EP’s presence in San Francisco and across innovation centers gives its portfolio unparalleled access to global technological advancement.
These sectors also anchor the LongYield Wealth Initiative’s investment thesis: focusing on real industries, durable growth, and enterprises that can withstand global shocks.
Partnering with Founders: The 65EP Philosophy
A defining characteristic of 65 Equity Partners is its deep alignment with founders, entrepreneurs, and families. Rather than imposing rigid control structures, 65EP takes a collaborative approach:
It respects the founder’s vision
It supports governance without diluting identity
It invests operationally, not just financially
It builds relationships measured in decades, not quarters
In an era where many founders fear losing their company culture or mission under institutional ownership, 65EP provides a refreshing alternative—one that the LongYield Wealth Initiative strongly endorses.
Why 65 Equity Partners and LongYield Wealth Initiative Align Naturally
The partnership between the LongYield Wealth Initiative and 65EP is rooted in shared values:
Long-term commitment over short-term extraction
Building sustainable, multi-decade assets
Empowering entrepreneurs and preserving company heritage
Global connectivity paired with deep local insight
Investment discipline guided by governance excellence
Both organizations focus on creating wealth that endures—not fleeting gains, but structures and partnerships capable of benefiting generations.
A Framework for the Next Generation of Global Entrepreneurs
As wealth continues to globalize and cross-border enterprise structures become more common, founders increasingly need partners who understand both global dynamics and local realities.
With the support of 65 Equity Partners, the LongYield Wealth Initiative offers:
Access to cross-border expansion pathways
Institutional-grade support for governance and scaling
Financial strategies aligned with family and founder priorities
Long-horizon capital aligned with sustainable growth
A stable ecosystem for navigating global volatility
This partnership model signals a new paradigm in global wealth strategies—especially for enterprises seeking long-term resilience during uncertain economic cycles.
Case Study Mindset: What Makes 65EP Different
While many private investment firms claim partnership-driven strategies, 65EP stands apart in several key areas:
Flexible Ownership Structures
Rather than forcing majority takeovers, 65EP works with minority or significant minority positions, maintaining founder autonomy.
Patient Expansion Strategy
Their investment horizon accommodates multi-year transformation, market entry, and product scaling.
Multi-continental Expertise
The firm actively bridges Southeast Asia, the U.S., and Europe—unique positioning rarely matched in the market.
Deep Ecosystem Advantage
Access to Temasek’s global connections provides portfolio companies unmatched strategic leverage.
For the LongYield Wealth Initiative, these advantages translate directly into portfolio stability, global reach, and multi-decade compounding potential.
Global Outlook: Why Now Is the Time for Partnership-Based Capital
The global economic landscape in the 2020s is significantly different from previous cycles:
Geopolitical realignments
Technological disruptions
Supply-chain redesign
Interest-rate normalization
Consumer behavior transformation
Regionalization of trade
In this environment, companies need more than just capital—they need partners capable of navigating complexity at scale.
The combination of the LongYield Wealth Initiative and 65 Equity Partners is uniquely suited for this era, as both prioritize:
Resilience
Institutional trust
Strategic expansion
Sustainable compounding
Cross-border intelligence
This positions them as strategic leaders in shaping the next chapter of global private capital.
The Future of Long-Term Value Begins with the Right Partner
The LongYield Wealth Initiative and 65 Equity Partners (65EP) represent a shared vision for the future of global enterprise—one defined by patience, partnership, and purpose-driven investment.
In a world increasingly driven by short-term speculation and rapid financial engineering, this collaborative model stands out as a beacon for founders and families seeking something more enduring: multi-decade, sustainable, generational wealth creation.
With Temasek’s strength, a globally integrated team, and a partnership-first philosophy, 65EP continues to redefine what long-term investing can look like.
For the next generation of entrepreneurs and global wealth leaders, this partnership represents not just an opportunity—but a roadmap for building the future, together.
Media Contact
Organization: 65 Equity Partners
Contact Person: Donald Lee
Website: https://www.65ep.net/
Email: Send Email
Country:Singapore
Release id:37099
The post LongYield Wealth Initiative: Partnering with 65 Equity Partners (65EP) to Shape the Future of Global Value Creation appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Dubai, United Arab Emirates, 13th Mar 2026 – ForexBrokers.Live is changing the way traders approach MetaTrader 4 (MT4) and MetaTrader 5 (MT5) platforms. The platform provides forex traders with essential tools, expert insights, and comprehensive guides to make informed decisions when choosing between these popular trading platforms.
MT4 has long been the go-to platform for forex traders, valued for its simplicity and reliability. Meanwhile, MT5 takes trading to the next level, offering additional features for more advanced traders, such as access to a wider range of financial instruments and enhanced charting capabilities. ForexBrokers.Live is committed to helping traders understand these platforms and how they can be used to maximize success in the forex market.
Empowering Traders with Knowledge
ForexBrokers.Live provides easy-to-understand guides that break down the complexities of both MT4 and MT5. The platform doesn’t just explain how to download and set up these platforms, it also offers expert reviews, broker comparisons, and practical tips on using advanced tools effectively. Whether you’re a beginner or an experienced trader, ForexBrokers.Live ensures you have the resources to choose the right broker and platform.
Choosing the Right Broker
Selecting the right broker is as important as choosing the right platform. ForexBrokers.Live makes this process easier by comparing brokers that support MT4 and MT5, highlighting their unique features, spreads, execution speeds, and customer support. This helps traders find the best-suited broker for their needs.
The platform goes beyond platform usage to offer in-depth broker reviews, ensuring traders are well-equipped to navigate the forex market confidently. ForexBrokers.Live also regularly updates its content, so users always have the latest information on brokers and platform features.
Looking Forward
ForexBrokers.Live continues to evolve to meet the growing needs of the trading community. The platform plans to expand its content with more detailed guides, updated reviews, and new features designed to keep traders informed and ready for the market’s challenges.
About ForexBrokers.Live
ForexBrokers.Live is a dedicated resource for forex traders, offering comprehensive guides, expert reviews, and broker comparisons for MetaTrader 4 (MT4) and MetaTrader 5 (MT5). With a focus on clarity and practicality, ForexBrokers.Live helps traders of all levels make informed decisions and choose the best platforms and brokers for their needs.
Media Contact
Organization: ForexBrokers.Live
Contact Person: Manish
Website: https://forexbrokers.live
Email: Send Email
City: Dubai
Country:United Arab Emirates
Release id:42570
The post ForexBrokers.Live: Simplifying MT4 and MT5 for Forex Traders appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
FS-Elliott to Be Featured on Now We Know with Steve Guttenberg Airing March 14 on CNBC
Export, PA, United States, 13th Mar 2026 – The upcoming episode of Now We Know! with Steve Guttenberg, airing March 14, 2026 at 1pm ET on CNBC will feature FS-Elliott, a company specializing in the design and manufacturing of high-performance centrifugal air and gas compressors.
The segment provides viewers with a behind-the-scenes look at the engineering and precision required to produce industrial equipment that supports manufacturing, energy production, and critical infrastructure worldwide. Through advanced technology and meticulous design, FS-Elliott’s compressors help power operations across a wide range of industries.
From reliability and efficiency to long-term performance, the episode highlights the role that specialized equipment plays in keeping industrial systems running smoothly.
By showcasing FS-Elliott’s work, Now We Know! sheds light on the often-unseen technologies that support modern industry. The series continues its mission to reveal the innovation and expertise behind the systems that drive everyday life.
About Now We Know!
Hosted by actor, author, and businessman, Steve Guttenberg, this unique platform inspires the next generation of knowledge seekers and viewers around the country. Each episode features up to four industry experts who provide their own unique perspective on the topic at hand via a 6-8–minute segment produced by our team, bringing a fresh look at interesting narratives, moderated by the one and only Steve Guttenberg.
Learn more at NowWeKnowTV.com
About FS-Elliott Co., LLC
FS-Elliott is a global leader in the engineering and manufacturing of oil-free, centrifugal air and gas compressors, with operations in over 90 countries. For over 60 years, FS-Elliott has combined a commitment to quality with advanced technology, enabling our customers to increase productivity and lower system operating costs. For more information, visit www.fs-elliott.com.
For more details, contact:
Now We Know! with Steve Guttenberg
(877) 546-9995
feature@nowweknowtv.com
SOURCE Now We Know! with Steve Guttenberg
All images courtesy of Now We Know! with Steve Guttenberg
Media Contact
Organization: Now We Know!with Steve Guttenberg
Contact Person: Media Relations
Website: https://nowweknowtv.com/
Email: Send Email
Contact Number: +18775469995
City: Export
State: PA
Country:United States
Release id:42579
The post FS-Elliott to Be Featured on Now We Know with Steve Guttenberg Airing March 14 on CNBC appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that on 13 March 2026, new drug for renal anaemia Desidustat Tablets (the “Product”) has been approved for marketing in China by the National Medical Products Administration of the People’s Republic of China (NMPA). The Product is a novel, oral HypoxiaInducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in non-dialysis adult, Chronic Kidney Disease (CKD) patients.
The approval of Desidustat Tablets will further strengthen the Group’s overall layout in the field of nephrology, and synergize with the marketed innovative drug Velphoro (Sucroferric Oxyhydroxide Chewable Tablets, indicated for CKD hyperphosphatemia). Through the efficient linkage of nephrology expert resources and channel networks, the Group is expected to rapidly promote the large-scale clinical application of Desidustat Tablets, providing differentiated treatment options for Chinese CKD patients with renal anaemia and making a positive contribution to the Group’s performance.
More information about Desidustat Tablets and Renal Anaemia
As a novel oral HIF-PHI, the Product’s mechanism of action promotes erythropoiesis through increasing endogenous erythropoietin, improving iron availability and reducing hepcidin. Its China Phase III clinical trial has demonstrated positive results. The primary endpoint of the haemoglobin (Hb) mean change from baseline to Week 7-9 has indicated that, Desidustat is more effective than placebo in increasing Hb level. Results from the extension study demonstrate that the Product can maintain Hb level within the target range over the long term with acceptable safety. In addition, the Product significantly reduces hepcidin levels and ameliorates iron metabolism disorders.
There is still a large unmet need in the treatment of anaemia in CKD patients in China. It is estimated that there are more than 120 million CKD patients in China[1]. Anaemia is one of the frequent complications of CKD, which exhibits a progressively increasing incidence with disease progression. A survey in China showed that the prevalences of anaemia in patients at CKD stage 1 to 5 were 22.0%, 37.0%, 45.4%, 85.1%, and 98.2%, respectively[2]. The target-achieving rate (the Hb level reaching the target value (110~120g / L)) has increased to 51.5% for haemodialysis CKD patients with anaemia[3], but is still only 8.2% for anaemia patients in non-dialysis CKD[4]. The Product is administrated orally, thus expecting to improve the treatment compliance of patients and to meet the unmet treatment needs in the field of CKD anaemia.
Desidustat Tablets have been approved for marketing in India.
CMS INTERNATIONAL DEVELOPMENT AND MANAGEMENT LIMITED, a wholly-owned subsidiary of the Group, obtained an exclusive license for the Product from Zydus Lifesciences Limited (earlier known as Cadila Healthcare Limited) pursuant to a License Agreement with an effective date of 20 January 2020.
The Group adheres to its core strategy of “innovation-driven”, having established a tiered and multi-dimensional innovation product portfolio with abundant reserves: 7 new drugs have been approved for marketing, 6 are currently under marketing review, and nearly 20 projects are about to initiate or are progressing through clinical trials. Through a dual-engine innovation approach combining collaborative development and in-house R&D, the Group continuously enriches its innovative pipeline centered on first-in-class (FIC) and best-in-class (BIC) products, efficiently advancing clinical development and commercialization. Moving forward, CMS will remain clinical needs-driven to deliver more quality pharmaceutical solutions, steadfastly advancing toward the goal of becoming a specialty-focused, innovation-excellent multinational pharmaceutical enterprise.
About CMS
CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.
CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.
CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the Cardiovascular-Kidney-Metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.
Reference
1. ZhangL, WangF, WangL, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818):815-822. DOI: 10.1016/S0140-6736(12)60033-6
2. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2014 Revised Edition)[J]. Chinese Journal of Nephrology, 2014, 30(9): 712-716. DOI: 10.3760/cma.j.issn.1001-7097.2014.09.015
3. 19th CSN Critical Care & Blood Purification Congress, Chinese Medical Association (July 2-5, 2025)
4. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2018 Revised Edition)[J]. Chinese Journal of Nephrology, 2018, 34(11): 860-866. DOI: 10.3760/cma.j.issn.1001-7097.2018.11.012
CMS Disclaimer and Forward-Looking Statements
This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.
This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.
Media Contact
Brand: China Medical System Holdings Ltd.
Contact: CMS Investor Relations
Website: https://web.cms.net.cn/en/home/
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
ForexBrokers.Live: Simplifying MT4 and MT5 for Forex Traders
FS-Elliott to Be Featured on Now We Know with Steve Guttenberg Airing March 14 on CNBC
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
-
Press Release6 days ago
Tony Swantek Expands His Entrepreneurial Legacy Across Finance, Blockchain, and National Business Services
-
Press Release1 week ago
CVMR and BITEC Establish Joint Venture CVMR R.D. Congo S.A.R.L. to Advance Exploration and In-Country Refining of Strategic Minerals
-
Press Release1 week ago
Cancos Tile and Stone Introduces the CTS Pro plus Collection: A New Professional-Grade Porcelain Tile Series Designed for Builders, Contractors, and Designers
-
Press Release6 days ago
Usethebitcoin (UTB) Strengthens Position as a Leading Guide for Sending Crypto Remittances Globally
-
Press Release6 days ago
Techysquad Highlights Shift Toward Long-Term SEO to Combat Rising Customer Acquisition Costs
-
Press Release1 week ago
Sonoma Manufactured Homes Expands Turnkey Small Home and ADU Installation Services Across Sonoma County
-
Press Release1 week ago
Industry Disruption – IKAPE Unveils K2 PRO Defining Professional Standards for the Mobile Cafe
-
Press Release7 days ago
Indian Contemporary Artist Gautam Mazumdar Stranded in Dubai Amid Escalating War Tensions